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www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM30 day mortality occurred in one patient (3.85%) due to paradox embolism and
mesenteric ischemia. Access site complications occurred in 2 patients (7.7%).
Conclusions: Submassive pulmonary embolism ha excellent results with catheter
directed thrombolysis, however additional mechanical thrombectomy and angioplasty
is necessary in several patients to achive good clinical outcome.
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Background: Massive Pulmonary Embolism (MPE) is an important cause of death
around the world. In unstable patients (pts), Percutaneous Rheolytic Thrombectomy
(PRT) is a treatment option, especially in those unable for surgical thrombectomy or
with absolute contraindications for ﬁbrinolysis. We are reporting retrospective in-
hospital and late outcome of unstable pts treated with PRT.
Methods: Between December 2009 and April 2013 in two university Hospitals in
Buenos Aires, Argentina, we included 14 consecutive pts with MPE according to the
American College of Chest Physicians guidelines and conﬁrmed by multislice
computed tomography and doppler ultrasound (US), moderate to severe right ventric-
ular failure and contraindication or ﬁbrinolysis therapy failure. All pts (or direct rela-
tives) signed an Informed Consent Form previously to treatment with Angiojet
thrombectomy system (Bayer HealthCare, Germany). Pre-procedure Shock Index (heart
rate/systolic arterial pressure) and pulmonary systolic pressure pre and post procedure
were obtained. Miller score was estimated after pulmonary angiogram was performed.
Primary endpoint was in-hospital death and any bleeding. During follow-up an US was
done at 3 months after discharge to assess right ventricular function and pulmonary
pressures. Long term follow-up was done to assess heart failure or functional class.
Results:Mean age was 64.5 +/- 14.3 years, 64.3% were male, with BMI>30¼71.4%,
previous malignant neoplasia in 14.2%, chronic obstructive pulmonary disease¼9.1%
and immobility¼71.4%. Pre-procedure shock index was 1.43+/-0.23. After procedure
Miller Score and systolic pulmonary pressures improved signiﬁcantly (p< 0.001 for
both). After PRT and before 30 days one patient died and no bleeding was reported.
During 25.7 +/-21 months of follow-up global mortality was 28.5% (none cardiac
related) and 2 pts showed evidence of mild cor pulmonale.
Conclusions: Percutaneous Pulmonary Rheolytic thrombectomy was safe and effec-
tive for the treatment of these high risk patients. Long-term outcome was related to the
underlying pathology.
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Background: There are limited therapuetic options for high risk patients with massive
or sub-massive pulmonary embolism. The use of ultrasound-assisted catheter directed
thrombolysis(UA-CDT) has shown to be particularly promising in various small
studies. We aimed to conduct a meta-analysis of the available published studies.
Methods: An extensive time unlimited literature search using MEDLINE, EMBASE
& Cochrane databases using MeSH key words ‘pulmonary embolism’, ‘ultrasound’
and ‘catheter-directed’ identiﬁed 7 studies including a total of 240 patients. Of these
197 patients underwent use of Ekosonic catheter directed thrombolytic therapy
(UCDT) for massive or sub-massive PE. Hemodynamic measures including mean &
systolic pulmonary artery pressure, RV-LV ratio, heart rate and cardiac index were
assessed before and after therapy. Meta-analysis was performed using Cochrane
Collaboration Review Manager(version 5.1). Effect size was estimated using random
effects model and mean difference with 95% conﬁdence intervals were calculated.
Results: One hundred and thirty patients were treated with UCDT. Massive &
bilateral PE was reported in 74(30.8%) & 152(63.3%) patients respectively. UCDT
resulted in a signiﬁcant reduction in PA systolic (mean -15.22mmHg;95% CI -21.01–
9.43) & mean PA pressures(mean -9.35mmHg;95% CI -13.03- -5.68), in addition to a
24% increase in cardiac index. The RV size, assessed by the ratio of RV to LV di-
mensions, was reduced with UCDT(mean -0.35;95% CI -0.42- -0.28), & the heart rate
decreased by 16.9 beats/min (95% CI -26.46 - -7.34). The Miller pulmonary artery
occlusion score (in 87 patients)showed a signiﬁcant reduction of 10.12 points (95% CI
-12.21 - -8.02). Thirty & 90-day all-cause mortality was 3.1% (6/197)& 4.6%(7/152)
respectively with UCDT. Recurrent events & major bleeding was reported in 2/
115(1.7%) & 7 patients(3.5%)respectively.
Conclusions: In this largest meta-analysis to-date evaluating the impact of UCDT on
massive & sub-massive PE, UCDT is associated with signiﬁcant improvements in
hemodynamic measures of RV & LV function. The procedure appears to be safe & is
associated with low 30 & 90-day mortality compared to RIETE(8.65%) and ICOPER
registries(17.4%).JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/PeTCT-514
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Background: To review feasibility, safety and long-term results of subclavian artery
angioplasty.
Methods: 407 patients (males: 245, mean age: 66.1  12 y) underwent percutaneous
treatment for subclavian artery (SA) occlusive disease (stenosis: 295, occlusion: 112).
Left: 312, Right: 95, Innominate Artery: 28. Etiology: atheromatous: 397, others: 10
(Takayasu: 6) Mean % stenosis 83.4 +/- 7.8. Mean lesion length: 23.9 +/- 8.7 mm
Indications for treatment were upper limb ischemia (ULI) (n¼177) Vertebrobasilar
insufﬁciency (VBI) (n¼157), associated VBI and ULI (n¼123), coronary steal syn-
drome (n¼20) asymptomatic patients with severe coronary disease (n¼73) 39 patients
had associated Vertebral Artery stenosis, 81 carotid stenoses. 337 prevertebral lesion,
45 post vertebral, both 25. Access: femoral (n¼287), brachial (n¼81), both (n¼39).
“Pull through technique”: 8 cases. An isolated balloon angioplasty was performed in 59
cases and 348 stents were implanted (balloon expandable: 276, self expandable: 72).
Results: Technical success was obtained in 387 lesions (95 %) 100% for stenoses.
Only 92 occlusions were recanalized (82 %). Four periprocedural events occurred (1.2
%), 1 major (fatal stroke), 1 T.I.A., 2 arterial thromboses. During the follow-up (mean
follow-up: 75.7 months  38.5), we had 40 restenoses (10 %). 13 occurred following
angioplasty alone (18.8 %) and 27 following angioplasty and stent implantation (7.8 %)
(P< 0.01). 10 were treated by new angioplasty alone, 30 by repeat stent implantation.
Primary (PI) and secondary (PII) patencies on an intention to treat basis at 10-year follow-
up were 80.2 % and 86.5 % respectively. In patients without initial stent placement,
the rates were 67.5 % and 75.5 % while in those with stents, the rates rose to 91.5 % and
98.2 % (P< 0.01). PI for all recanalized lesions were 85.8 %, 79.1 % without stent, 91.8
% with stent (P < 0.04) and PII 92.8 %, 88.5 %, 98.1% respectively (P < 0.02).
Conclusions: P.T.A. is currently the treatment of choice for subclavian artery lesions.
It is a safe and effective procedure associated with low risks and good long-term
results. Stents seem to limit the restenosis rate and improve long-term results.
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Background: Erectile Dysfunction (E D) is an important and growing health problem.
It is estimated that more than 200 million men (between the age of 40 – 70 years)
suffer from ED . The real prevalence could be much higher as it is under reported and
under treated. Out of the many etiologies, 80 % of cases are because of vasculogenic
origin. Venous leak and Arterial Inﬂow problems (usually pudendal artery stenosis)
are the most common etiologies. In patients who fail PDE – 5 inhibitors therapy
(Complex ED), vasculogenic causes should be strongly suspected.
Methods: The workup is done by excluding the endocrinal, urological and psychological
causes and then subjecting these patients to a penile Doppler study (after intra cavernosal
injection of papaverine). In patients where the peak systolic penile velocity is less than
25 cm /sec, pudendal artery stenosis is strongly suspected. These patients then undergo a
selective angiography for identiﬁcation of pudendal artery stenosis. If the stenosis is
found they are subjected to super selective pudendal artery cannulation and angioplasty
or stenting using drug eluting balloon (DEB) or zatrolimus eluting stents (DES). Patients
are followed up at 3, 9, 12 months and then after every year by Duplex scans.
Results: 36 consecutive worked up patients of complex ED with pudendal artery ste-
nosis underwent pudendal artery angioplasty (with DEB or DES). The procedure was
successful in all patients There were no death, perineal or penile gangrene. The mean
penile velocity increased from base line of 16 cm / sec to 44 ,50,58 cm /sec at 3, 6, 12
months respectively. Improvement > 4 points in International Index of Erectile Func-
tions (IIEF -6 ) score at 3 , 6 and 12 months were 68 % , 75 % and 78 % respectively.
Conclusions: Angioplasty of focal stenosis of internal pudendal artery by DEB or
DES appears to be a very promising therapy for male erectile dysfunction. It is safe,
feasible and leads to sustained improvement of male erectile dysfunction in about 75
% of carefully selected cases. However still many cases are ineligible for this pro-
cedure . Larger studies are required to be able to accept it as a standard therapy to treat
male Erectile Dysfunction.
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Background: Arterial aneurysms (An) are traditionally treated surgically, but more
and more by interventional procedures with a high technical success rate, but some
problems are not solved like protection of aneurysm rupture, endoleaks, stentripheral Vascular: Miscellaneous and Other B151
